Cargando…
Major Bleeding Complications and Persistence With Oral Anticoagulation in Non‐Valvular Atrial Fibrillation: Contemporary Findings in Real‐Life Danish Patients
BACKGROUND: The nonvitamin K antagonist oral anticoagulants have recently become available as an alternative to warfarin as stroke prophylaxis in atrial fibrillation, but data on real‐life patient experience, including bleeding risk, are lacking. Our objective was to compare major bleeding events an...
Autores principales: | Lamberts, Morten, Staerk, Laila, Olesen, Jonas Bjerring, Fosbøl, Emil Loldrup, Hansen, Morten Lock, Harboe, Louise, Lefevre, Cinira, Evans, David, Gislason, Gunnar Hilmar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5523754/ https://www.ncbi.nlm.nih.gov/pubmed/28196815 http://dx.doi.org/10.1161/JAHA.116.004517 |
Ejemplares similares
-
Non-vitamin K antagonist oral anticoagulation usage according to age among patients with atrial fibrillation: Temporal trends 2011–2015 in Denmark
por: Staerk, Laila, et al.
Publicado: (2016) -
Temporal trends in initiation of VKA, rivaroxaban, apixaban and dabigatran for the treatment of venous thromboembolism - A Danish nationwide cohort study
por: Sindet-Pedersen, Caroline, et al.
Publicado: (2017) -
Dabigatran use in Danish atrial fibrillation patients in 2011: a nationwide study
por: Sørensen, Rikke, et al.
Publicado: (2013) -
Comparative thromboembolic risk in atrial fibrillation with and without a secondary precipitant—Danish nationwide cohort study
por: Gundlund, A, et al.
Publicado: (2019) -
Familial Clustering of Venous Thromboembolism – A Danish Nationwide Cohort Study
por: Sindet-Pedersen, Caroline, et al.
Publicado: (2016)